tiprankstipranks
Trending News
More News >

Envoy Medical initiated with a Buy at Ascendiant

Ascendiant initiated coverage of Envoy Medical with a Buy rating and $8.50 price target. The company’s medical devices are designed to bring both providers and patients hearing devices with improved technology, ease of use, access, usability, independence, and quality of life, the analyst tells investors in a research note. The firm sees large market opportunities for Envoy’s Acclaim CI to treat hearing loss. It believes positive clinical milestones in 2024 will be “strong catalysts” for the stock.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue